Facebook
Twitter
Telegram
Fehler meldenEvoke Pharma Finanzdaten 2011-2024 | EVOK
Jahresabschluß Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.24 M | 9.81 M | 20.5 M | 67.5 M | 32.6 M | 46.8 M | 40.7 M | 26.6 M | 20.5 M | 39 M | 24.3 M | - | - |
Anteile |
3.34 M | 3.14 M | 2.68 M | 26.1 M | 22.3 M | 16.6 M | 14.9 M | 9.34 M | 6.49 M | 6.03 M | 2.37 M | - | - |
Kurshistorie |
0.67 | 3.12 | 7.66 | 35.4 | 14.8 | 37 | 23.4 | 39.5 | 41.2 | 67.1 | 125 | - | - |
Nettogewinn |
-7.79 M | -8.22 M | -8.54 M | -13.2 M | -7.13 M | -7.57 M | -12.2 M | -10.7 M | -12.1 M | -13.2 M | -2.84 M | -2.02 M | -2.4 M |
Umsatz |
5.18 M | 2.51 M | 1.62 M | 23 K | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | -63.7 K | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-7.43 M | -7.79 M | -8.15 M | -13 M | -7.15 M | -8.01 M | -11.2 M | -10.5 M | -11.8 M | -13.2 M | -2.6 M | -2 M | -2.41 M |
Zinsaufwendungen |
500 K | 500 K | 500 K | 113 K | - | - | - | - | - | 108 K | 160 K | - | - |
EBITDA |
-7.43 M | -7.79 M | -8.15 M | -13 M | -7.15 M | -8.45 M | -10.2 M | -11.1 M | -11.5 M | -13.1 M | -2.59 M | -2 M | -2.4 M |
Betriebsaufwand |
12.6 M | 10.3 M | 9.77 M | 13 M | 7.15 M | 8.01 M | 11.2 M | 10.5 M | 11.8 M | 13.2 M | 2.6 M | - | - |
Allgemeine und Verwaltungsausgaben |
12.2 M | 9.62 M | 8.85 M | 6.43 M | 3.74 M | 3.92 M | 4.09 M | 3.59 M | 3.66 M | 3.16 M | 1.64 M | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Evoke Pharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
9.08 M | 3.34 M | 3.34 M | 3.34 M | 3.34 M | 3.34 M | 3.34 M | 3.16 M | 2.73 M | 2.72 M | 2.71 M | 2.7 M | 31.2 M | 26.6 M | 26.1 M | 25 M | 24.4 M | 24.3 M | 24.1 M | 23.3 M | 17.5 M | 17.4 M | 17.1 M | 16.4 M | 15.4 M | 15.4 M | 15.4 M | 15.3 M | 13.5 M | 12.3 M | 10.6 M | 7.22 M | 7.17 M | 7.12 M | 6.49 M | 6.21 M | 6.1 M | 6.07 M | 6.05 M | 6.03 M | 6 M | 5.97 M | 1.19 M | 1.14 M | 1.13 M | 1.13 M | 1.13 M | 1.12 M | 1.12 M | - | - | - | - |
Nettogewinn |
-1.58 M | - | -1.69 M | -1.87 M | -2.24 M | - | -2.01 M | -2.23 M | -2.17 M | - | -1.97 M | -2.29 M | -2.61 M | - | -2.13 M | -6.97 M | -1.79 M | -1.42 M | -1.63 M | -2.11 M | -1.97 M | -1.76 M | -1.52 M | -2.3 M | -1.98 M | -308 K | -5.24 M | -1.63 M | -5.05 M | -1.53 M | -3.03 M | -2.97 M | -3.23 M | -2.62 M | -2.74 M | -3.24 M | -3.52 M | -2.92 M | -3.83 M | -3.55 M | -2.96 M | -1.62 M | -486 K | -240 K | -494 K | -672 K | -486 K | -359 K | -500 K | - | - | - | - |
Umsatz |
1.74 M | - | 1.56 M | 1.13 M | 810 K | - | 832 K | 462 K | 418 K | - | 930 K | 237 K | 90.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-1.5 M | - | -1.6 M | -1.78 M | -2.16 M | - | -1.91 M | -2.11 M | -2.05 M | - | -1.84 M | -2.17 M | -2.59 M | - | -2.08 M | -6.96 M | -1.79 M | - | -1.64 M | -2.12 M | -1.97 M | - | -1.52 M | -2.31 M | -2.42 M | - | -3.7 M | -2.89 M | -1.98 M | - | -2.17 M | -2.9 M | -3.15 M | - | -2.66 M | -3.16 M | -3.45 M | - | -3.82 M | -3.49 M | -2.92 M | - | -486 K | -203 K | -332 K | - | -478 K | - | - | - | - | - | - |
Zinsaufwendungen |
125 K | - | 126 K | 125 K | 123 K | - | 126 K | 125 K | 123 K | - | 126 K | 125 K | 123 K | - | 50.5 K | 2.91 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78.4 K | 77.7 K | 77 K | - | 5.91 K | 58.4 K | 36.9 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-1.5 M | - | -1.6 M | -1.78 M | -2.16 M | - | -1.91 M | -2.11 M | -2.05 M | - | -1.84 M | -2.17 M | -2.59 M | - | -2.08 M | -6.96 M | -1.79 M | - | -1.64 M | -2.12 M | -1.97 M | - | -1.52 M | -2.31 M | -2.42 M | - | -3.7 M | -2.89 M | -1.98 M | - | -2.17 M | -2.9 M | -3.15 M | - | -2.66 M | -3.16 M | -3.45 M | - | -3.82 M | -3.49 M | -2.92 M | - | -486 K | -203 K | -332 K | - | -478 K | - | - | - | - | - | - |
Betriebsaufwand |
3.24 M | - | 3.17 M | 2.92 M | 2.97 M | - | 2.74 M | 2.57 M | 2.47 M | - | 2.78 M | 2.41 M | 2.68 M | - | 2.08 M | 6.96 M | 1.79 M | - | 1.64 M | 2.12 M | 1.97 M | - | 1.52 M | 2.31 M | 2.42 M | - | 3.7 M | 2.89 M | 1.98 M | - | 2.17 M | 2.9 M | 3.15 M | - | 2.66 M | 3.16 M | 3.45 M | - | 3.82 M | 3.49 M | 2.92 M | - | 486 K | 203 K | 332 K | - | 478 K | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
3.14 M | - | 3.13 M | 2.77 M | 2.85 M | - | 2.61 M | 2.32 M | 2.41 M | - | 2.64 M | 2.14 M | 2.34 M | - | 1.87 M | 1.18 M | 1.33 M | 783 K | 814 K | 918 K | 1.22 M | 1.07 M | 897 K | 917 K | 1.03 M | 1.03 M | 984 K | 872 K | 1.21 M | 822 K | 830 K | 803 K | 1.14 M | 843 K | 820 K | 976 K | 1.03 M | 738 K | 733 K | 617 K | 1.07 M | 944 K | 407 K | 72.6 K | 221 K | 344 K | 141 K | 147 K | 205 K | - | - | - | - |
Alle Zahlen in USD-Währung